RPA
FLNA

Redwood Park Advisors’s Filana Therapeutics FLNA Stock Holding History

Redwood Park Advisors’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$48 Buy
+40
New +$57 ﹤0.01% 349

Other funds holding FLNA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Redwood Park Advisors's FLNA Position: Q2 2026 in Review

Redwood Park Advisors opened a new position in Filana Therapeutics (FLNA) in Q2 2026: 40 shares worth $48. The stake represents ﹤0.01% of the portfolio and ranks #349 among its holdings.

85 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

  • Redwood Park Advisors held 40 shares of Filana Therapeutics worth $48 as of Q2 2026.
  • Filana Therapeutics was a new Redwood Park Advisors position in Q2 2026.
  • Filana Therapeutics made up ﹤0.01% of Redwood Park Advisors's portfolio in Q2 2026, its #349 holding.
  • 85 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on Redwood Park Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.